This study builds upon two previous reports exploring the effects of RANKL inhibition on murine FD models, reporting increased lesion mineralization and density.6,7 Liu Z et al. also observed decreased ALP expression and increased OCN+ mature osteoblasts,6 providing the first evidence that RANKL inhibition may impact osteogenesis. This evidence concerns the gene TNFSF11 and Fabry disease.